ArticleKidney international reports2025
Reassessing Rituximab in Membranous Nephropathy: Efficacy, Limitations, and the Path Ahead.
Anne-Els van de Logt et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it